CSat Investment Advisory, L.P. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
CSat Investment Advisory, L.P. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$34,0000.0%245
+15.0%
0.00%
-25.0%
Q2 2020$34,000
-39.3%
213
-62.7%
0.00%
-66.7%
Q1 2020$56,000
-9.7%
571
+19.7%
0.01%
-25.0%
Q4 2019$62,000
-44.1%
477
-67.7%
0.02%
-54.3%
Q3 2019$111,000
-39.7%
1,477
+22.1%
0.04%
-46.2%
Q2 2019$184,0001,2100.06%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders